HighCape Capital Acquisition Corp. Cl A (CAPA): Price and Financial Metrics
GET POWR RATINGS... FREE!
CAPA Stock Price Chart Interactive Chart >
CAPA Price/Volume Stats
|Current price||$10.68||52-week high||$25.00|
|Prev. close||$10.55||52-week low||$9.85|
|Day high||$10.83||Avg. volume||805,826|
|50-day MA||$10.59||Dividend yield||N/A|
|200-day MA||$0.00||Market Cap||157.85M|
HighCape Capital Acquisition Corp. Cl A (CAPA) Company Bio
HighCape Capital Acquisition Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses for its initial business. The company was founded on June 10, 2020 and is headquartered in New York, NY.
Most Popular Stories View All
CAPA Latest News Stream
|Loading, please wait...|
CAPA Latest Social Stream
View Full CAPA Social Stream
Latest CAPA News From Around the Web
Below are the latest news stories about HighCape Capital Acquisition Corp that investors may wish to consider to help them evaluate CAPA as an investment opportunity.
Quantum-Si, Revolutionizing Proteomics, Closes Business Combination and Will Begin Trading Under the Ticker "QSI" on the Nasdaq Stock Exchange
Quantum-Si Incorporated (Nasdaq: QSI) ("Quantum-Si," "QSi" or "the Company"), a company pioneering next-generation semiconductor chip-based proteomics, today announced that it has completed its business combination with HighCape Capital Acquisition Corp. (Nasdaq: CAPA) ("HighCape"), a special purpose acquisition company sponsored by leading healthcare growth equity manager HighCape Capital LP. The business combination and concurrent private placement, which were approved by HighCape’s stockholde
HighCape Capital Acquisition Corp. Reminds Stockholders to Vote in Favor of the Business Combination with Quantum-Si Incorporated
NEW YORK, June 02, 2021 (GLOBE NEWSWIRE) -- HighCape Capital Acquisition Corp. (Nasdaq: CAPA) (“HighCape”), a special purpose acquisition company sponsored by leading healthcare growth equity investment firm HighCape Capital LP, reminds its stockholders of record as of the close of business on May 10, 2021 to vote at the upcoming special meeting of stockholders held virtually at https://www.cstproxy.com/highcape/sm2021 on June 9, 2021 at 10:00 a.m. Eastern Time (the “Special Meeting”) to approve
Quantum-Si and HighCape Capital Acquisition Corp. Announce Effectiveness of Registration Statement for Proposed Business Combination
Special meeting of HighCape stockholders scheduled for June 9, 2021NEW YORK and GUILFORD, Conn., May 17, 2021 (GLOBE NEWSWIRE) -- Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, and HighCape Capital Acquisition Corp. (“HighCape”), a healthcare-focused special purpose acquisition company (SPAC), today announced that the Securities and Exchange Commission (“SEC”) has declared the Registration Statement on Form S-4 in connection with the proposed business combination between the two companies, to be effective. A special meeting of HighCape stockholders (the "Special Meeting") to approve, among other things, the proposed business combination, will be held in virtual format on June 9, 2021 at 10:00 a.m. Eastern Time. HighCape also announced ...
Quantum-Si Incorporated, a company pioneering next-generation semiconductor chip-based proteomics, announced today the appointment of Marijn Dekkers, Ph.D. and Ruth Fattori to its Board of Directors. Both Dr. Dekkers and Ms. Fattori have agreed to continue to serve on the Board of Directors of the combined company subsequent to the closing of the previously announced business combination between Quantum-Si and HighCape Capital Acquisition Corp (Nasdaq: CAPA).
Quantum-Si Incorporated, a pioneer in next-generation semiconductor chip-based proteomics, announced today the appointment of Claudia Napal Drayton as Chief Financial Officer.
CAPA Price Returns